Literature DB >> 7884091

Prognosis of left ventricular geometric patterns in the Framingham Heart Study.

H M Krumholz1, M Larson, D Levy.   

Abstract

OBJECTIVES: The goal of this study was to determine the incremental prognostic value of left ventricular geometric patterns beyond that provided by cardiovascular disease risk factors, including left ventricular mass.
BACKGROUND: Left ventricular geometry may be classified into the following four mutually exclusive groups on the basis of left ventricular mass and relative wall thickness: concentric hypertrophy (increased mass and increased relative wall thickness), eccentric hypertrophy (increased mass and normal relative wall thickness), concentric remodeling (normal mass and increased relative wall thickness) and normal geometry (normal mass and normal relative wall thickness). The prognosis associated with these patterns in a population-based sample is not known.
METHODS: Proportional hazards regression models were used to evaluate the prognostic importance of left ventricular geometry in 3,216 subjects in the Framingham Heart Study who were > or = 40 years old and free of clinically apparent cardiovascular disease, after adjustment for traditional cardiovascular risk factors and left ventricular mass. The follow-up period was 8 years.
RESULTS: Subjects with concentric hypertrophy had the worst prognosis, followed by those with eccentric hypertrophy, concentric remodeling and normal geometry. Subjects with concentric hypertrophy also had the highest left ventricular mass. The association between type of geometry and prognosis was largely attenuated by adjustment for baseline differences in left ventricular mass. The odds ratio for incident cardiovascular disease in subjects with concentric hypertrophy compared with those who had normal geometry was 1.3 (95% confidence interval [CI] 0.8 to 2.1) in men and 1.2 (95% CI 0.6 to 2.3) in women after adjustment for other cardiovascular risk factors, including left ventricular mass.
CONCLUSIONS: In a population-based sample of subjects without cardiovascular disease, knowledge of left ventricular geometry provided little prognostic information beyond that available from left ventricular mass and traditional cardiovascular risk factors.

Entities:  

Mesh:

Year:  1995        PMID: 7884091     DOI: 10.1016/0735-1097(94)00473-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  108 in total

1.  Technetium-99m sestamibi cavity/myocardium count ratio in the detection of left ventricular hypertrophy.

Authors:  Gulay Durmus Altun; Osman Akdemir; Funda Ustun; Armagan Altun; Ali Sarikaya; Sakir Berkarda
Journal:  Clin Cardiol       Date:  2003-03       Impact factor: 2.882

2.  Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance.

Authors:  Julio A Chirinos; Patrick Segers; Marc L De Buyzere; Richard A Kronmal; Muhammad W Raja; Dirk De Bacquer; Tom Claessens; Thierry C Gillebert; Martin St John-Sutton; Ernst R Rietzschel
Journal:  Hypertension       Date:  2010-05-10       Impact factor: 10.190

3.  Elongation as a new shape index for the left ventricle.

Authors:  B Knap; G Juznic; A F Bren; G Drzewiecki; A Noordergraaf
Journal:  Int J Cardiovasc Imaging       Date:  2002-12       Impact factor: 2.357

4.  Myocardial adaptation in different endurance sports: an echocardiographic study.

Authors:  J Hoogsteen; A Hoogeveen; H Schaffers; P F F Wijn; N M van Hemel; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2004-02       Impact factor: 2.357

Review 5.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

Review 6.  Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?

Authors:  Sandeep Kamath; David Markham; Mark H Drazner
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

7.  Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.

Authors:  Koki Nakanishi; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Aylin Tugcu; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Am Heart J       Date:  2016-12-21       Impact factor: 4.749

8.  Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael J Pencina; Jayashri Aragam; Thomas J Wang; Daniel Levy; Ralph B D'Agostino; Douglas S Lee; William B Kannel; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

9.  Left atrial and ventricular dimensions in highly trained cyclists.

Authors:  J Hoogsteen; A Hoogeveen; H Schaffers; P F F Wijn; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

10.  Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function.

Authors:  Lisa de las Fuentes; Alan D Waggoner; B Selma Mohammed; Richard I Stein; Bernard V Miller; Gary D Foster; Holly R Wyatt; Samuel Klein; Victor G Davila-Roman
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.